Agent elevating dendritic cell precursor level in blood

Abstract From the Canadian patent

Although the therapeutic application range of dendritic cells has been more and more enlarged, dendritic cell precursors occur only in a small amount in peripheral blood. Therefore, it is still difficult to obtain dendritic cell precursors in a therapeutically available amount even though these precursors are grown in vitro. To effect a therapy with the use of dendritic cells in practice, accordingly, it is a key factor to elevate the dendritic cell precursor level in the peripheral blood of a patient. An agent elevating the dendritic cell precursor level in blood which comprises as the active , ingredient, an agonist to a receptor expressed in immature dendritic cells or its …